Study on the glucocorticoid [corticosteroid]-sparing effects of tocilizumab among glucocorticoid-dependent patients with adult Still's disease and systemic juvenile idiopathic arthritis: the open trial.
Phase of Trial: Phase IV
Latest Information Update: 16 Jul 2013
At a glance
- Drugs Tocilizumab (Primary)
- Indications Adult-onset Still's disease; Juvenile rheumatoid arthritis
- Focus Therapeutic Use
- 15 Jan 2010 Actual initiation date (Jul 2008) added as reported by University Hospital Medical Information Network - Japan.
- 15 Jan 2010 Status changed from not yet recruiting to recruiting as reported by University Hospital Medical Information Network - Japan.
- 16 Jul 2008 New trial record.